LADENBURG THALMANN FINANCIAL SERVICES INC. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 137 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,0000.0%500.0%0.00%
Q4 2018$1,000
-92.9%
50
-91.8%
0.00%
Q3 2018$14,000
-30.0%
609
-46.3%
0.00%
Q3 2017$20,000
+122.2%
1,134
+116.0%
0.00%
Q2 2017$9,000
-96.9%
525
-97.4%
0.00%
-100.0%
Q1 2017$287,000
-10.9%
20,525
+1.7%
0.00%0.0%
Q4 2016$322,000
-3.3%
20,191
+1.0%
0.00%
-20.0%
Q3 2016$333,000
+48.7%
20,0000.0%0.01%
+25.0%
Q2 2016$224,000
+34.1%
20,0000.0%0.00%
+33.3%
Q1 2016$167,000
-10.2%
20,0000.0%0.00%0.0%
Q4 2015$186,000
-17.7%
20,0000.0%0.00%
-40.0%
Q3 2015$226,000
-37.7%
20,000
-30.1%
0.01%
-28.6%
Q2 2015$363,000
+36.5%
28,6000.0%0.01%
+40.0%
Q1 2015$266,000
-36.4%
28,600
-2.0%
0.01%
-44.4%
Q4 2014$418,000
+38.0%
29,1750.0%0.01%
+12.5%
Q3 2014$303,000
-35.8%
29,1750.0%0.01%
-38.5%
Q2 2014$472,000
-0.4%
29,1750.0%0.01%
-7.1%
Q1 2014$474,000
+27.4%
29,175
-2.8%
0.01%
+27.3%
Q4 2013$372,000
+7.8%
30,000
-4.8%
0.01%
-8.3%
Q3 2013$345,000
+42.6%
31,500
+5.0%
0.01%
+33.3%
Q2 2013$242,00030,0000.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders